InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（6 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
6
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Moore John R, Conseiller Juridique Général. Director active across 1 company, notably Edgewise Therapeutics, Inc.. In total, 24 reports have been logged. Breakdown: 0 buy · 6 sells. Total volume traded: €348k. History available since 28 December 2021. The latest transaction was filed on 12 August 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Moore John R
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报24 总计
5,781 股0Common StockSEC:0001191702-26-000001:0
6,718 股0Common StockSEC:0001191702-26-000001:1
59 股@ US$44.41420.0001% mcap0.4% 占其流量Common StockSEC:0001191702-26-000001:3
99 股@ US$44.50190.0001% mcap0.7% 占其流量Common StockSEC:0001191702-26-000001:4
2,419 股@ US$43.79850.0024% mcap17.7% 占其流量Common StockSEC:0001191702-26-000001:5
2,439 股@ US$43.80810.0025% mcap17.8% 占其流量Common StockSEC:0001191702-26-000001:2
5,781 股0Common StockSEC:0001562180-25-005799:0
5,209 股0Common StockSEC:0001562180-25-003659:0
50,000 股@ US$0.719.5% 占其流量Common StockSEC:0001562180-24-006946:0
5,208 股0Common StockSEC:0001562180-24-003830:0
17,993 股@ US$1.939.6% 占其流量Common StockSEC:0001562180-24-001227:0
8,497 股@ US$10.5024.1% 占其流量Common StockSEC:0001562180-23-008572:0
5,208 股0Common StockSEC:0001562180-23-003922:0
4,730 股@ US$1.932.8% 占其流量Common StockSEC:0001562180-22-007050:0
4,730 股@ US$1.932.8% 占其流量Common StockSEC:0001562180-22-006557:0
4,730 股@ US$1.932.7% 占其流量Common StockSEC:0001562180-22-005918:0
3,684 股@ US$1.932.1% 占其流量Common StockSEC:0001562180-22-005621:0
14,722 股@ US$1.930.0006% mcap17.3% 占其流量Common StockSEC:0001562180-22-005251:0
4,093 股@ US$0.710.5% 占其流量Common StockSEC:0001562180-22-005126:0
12,566 股@ US$0.711.6% 占其流量Common StockSEC:0001562180-22-005053:0
15,230 股@ US$1.935.3% 占其流量Common StockSEC:0001562180-22-004887:0
10,800 股@ US$7.420923.4% 占其流量Common StockSEC:0001562180-22-004201:0
5,400 股@ US$0.711.0% 占其流量Common StockSEC:0001562180-22-000645:0
5,400 股@ US$0.711.0% 占其流量Common StockSEC:0001562180-21-007920:0
24 条申报中的 24 条
About Moore John R
MOORE JOHN R is General Counsel at Edgewise Therapeutics, Inc. (XNAS). He has 18 filings in total, and across the sampled recent filings from 2021-12-30 to 2025-08-14, buy volume is EUR 0 and sell volume is EUR 157567. The most frequent transaction type is Option exercise.
